|
|
|
|
Company Financials: Progenics Pharmaceuticals, Inc
Published By: Datamonitor Order Code: R313-61717 Description Introduction The Company Financials offers insights into the financial performance of the company over last five years for about 1000 leading global companies.The datapack covers wealth of...
|
|
|
Morphine may accelerate cancer growth, research suggests
CHICAGO - Evidence is mounting that morphine, commonly used to manage pain, may accelerate cancer growth, but a newly-approved drug that blocks its side effects could also keep tumours from spreading, U.S.researchers said on Wednesday. They said the...
|
|
|
Pfizer Q4 Revenues Up 34%
Pfizer has reported revenues of $16.53 billion for the fourth quarter of 2009, an increase of 34 percent compared with $12.34 billion for the same period in 2008.The company has reported a net income (attributable to the company) of $767m for the fourth...
|
|
|
Wyeth Can't Save Pfizer
Investors better hope that Pfizer (NYSE: PFE) can keep that fat dividend going, because earnings growth certainly won't drive its share price higher.Despite adding substantial revenue from Wyeth, the bottom line won't grow much. Increased interest expenses...
|
|
|
Wyeth Can't Save Pfizer
Recs 0 //Create your sharelet with desired properties and set button element to false object //Tie customized button to This button functionality.element Disney Buys Marvel! David Gardner called it! Hes up 1,334%! See what Davids recommending that you...
|
|
|
Wyeth Can't Save Pfizer
Investors better hope that Pfizer (NYSE: PFE) is able to keep that fat dividend going because earnings growth certainly isn't going to drive the share price higher.Despite adding substantial revenue from Wyeth, the bottom line isn't going to grow much.
|
|
|
Wyeth Can't Save Pfizer
Investors better hope that Pfizer (NYSE: PFE) is able to keep that fat dividend going because earnings growth certainly isn't going to drive the share price higher.Despite adding substantial revenue from Wyeth, the bottom line isn't going to grow much.
|
|
|
Morphine may accelerate cancer growth, research suggests
HICAGO - Evidence is mounting that morphine, commonly used to manage pain, may accelerate cancer growth, but a newly-approved drug that blocks its side effects could also keep tumours from spreading, U.S.researchers said on Wednesday. They said the...
|
|
|
Recently released market study: Progenics Pharmaceuticals, Inc. - SWOT Analysis
Datamonitor's Progenics Pharmaceuticals, Inc.- SWOT Analysis company profile is the essential source for top-level company data and information. Progenics Pharmaceuticals, Inc. - SWOT Analysis examines the companys key business structure and operations,...
|
|
|
Ono Pharmaceutical Co., Ltd. - Financial And Strategic Analysis Review - New Report Published
Newly released report, Ono Pharmaceutical Co., Ltd.- Financial and Strategic Analysis Review, provides detailed company analysis Published on December 10, 2009by Press Office(Companiesandmarkets.com and OfficialWire)LONDON, ENGLAND Ono Pharmaceutical Co.,...
|
